Potassium Hydroxide → N-[Pyrrolidin-3-yl]-6-methyl-2-(1-oxido-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)thieno[3,2-d]pyrimidin-4-amine
Reaction equation
C(OC([N:11]1[CH2:15][CH2:14][CH:13]([NH:16][C:17]2[C:22]3[S:23][C:24]([CH3:26])=[CH:25][C:21]=3[N:20]=[C:19]([N:27]3[CH2:33][C:32]4[CH:34]=[CH:35][CH:36]=[CH:37][C:31]=4[S:30](=[O:38])[CH2:29][CH2:28]3)[N:18]=2)[CH2:12]1)=O)C1C=CC=CC=1.[OH-].[K+]>CO>[NH:11]1[CH2:15][CH2:14][CH:13]([NH:16][C:17]2[C:22]3[S:23][C:24]([CH3:26])=[CH:25][C:21]=3[N:20]=[C:19]([N:27]3[CH2:33][C:32]4[CH:34]=[CH:35][CH:36]=[CH:37][C:31]=4[S:30](=[O:38])[CH2:29][CH2:28]3)[N:18]=2)[CH2:12]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a suspension of benzyl-3-{[2-(1-oxido-2,3-dihydro-1,4-benzothiazepin-4(5H)-yl)-6-methylthienopyrimidin-4-yl]amino}-pyrrolidine-1-carboxylate (300 mg, 0.55 mmol) in methanol (5 mL) was added an aqueous solution of potassium hydroxide (40%, 5 mL). The suspension was heated under reflux for 30 minutes. The organic solvent was removed by concentration in vacuo. The residue was purified by preparative HPLC to afford the pure product as a white solid. MS obsd. (ESI+) [(M+H)+] 414, 1H NMR (METHANOL-d4) δ ppm 7.73 (d, J=7.6 Hz, 1H), 7.68 (d, J=7.1 Hz, 1H), 7.37-7.52 (m, 2H), 6.77-6.85 (m, 1H), 5.19 (d, J=15.4 Hz, 1H), 4.79-4.97 (m, 3H), 4.71 (br. s., 1H), 3.44 (d, J=3.0 Hz, 2H), 3.25-3.38 (m, 2H), 3.21 (d, J=5.8 Hz, 1H), 3.02-3.13 (m, 1H), 2.54 (s, 3H), 2.34 (td, J=12.9, 6.9 Hz, 1H), 1.95-2.07 (m, 1H).
Workup
- temperatureThe suspension was heated
- temperatureunder reflux for 30 minutes
- customThe organic solvent was removed by concentration in vacuo
- customThe residue was purified by preparative HPLC
Sources & evidence
- ORD record
- ord-13a44d9b26b6475f901e6425653af0b8
- Source dataset
- uspto-grants-2013_12
- Patent number
- US08604019B2
Reaction notes
Loading…